UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED BALANCE SHEET (USD $) In Thousands, unless otherwise specified	Mar. 31, 2015	Dec. 31, 2014
Current assets:
Cash	$ 16,102	$ 19,274
Investments, available-for-sale	55us-gaap_InvestmentsFairValueDisclosure	58us-gaap_InvestmentsFairValueDisclosure
Accounts & other receivables, net	5,013us-gaap_AccountsReceivableNetCurrent	4,703us-gaap_AccountsReceivableNetCurrent
Inventories	4,850us-gaap_InventoryNet	4,872us-gaap_InventoryNet
Other current assets	769us-gaap_OtherAssetsCurrent	768us-gaap_OtherAssetsCurrent
Total current assets	26,789us-gaap_AssetsCurrent	29,675us-gaap_AssetsCurrent
Property and equipment, net	7,728us-gaap_PropertyPlantAndEquipmentNet	8,236us-gaap_PropertyPlantAndEquipmentNet
Goodwill	14,767us-gaap_Goodwill	15,145us-gaap_Goodwill
Other intangible assets	37,899	39,675
Other intangible assets - accumulated amortization	(11,808)	(11,655)
Other intangible assets, net	26,091	28,020
TOTAL ASSETS	75,375us-gaap_Assets	81,076us-gaap_Assets
Current liabilities:
Accounts payable	807us-gaap_AccountsPayableCurrent	929us-gaap_AccountsPayableCurrent
Accrued expenses	4,552us-gaap_AccruedLiabilitiesCurrent	4,148us-gaap_AccruedLiabilitiesCurrent
Current portion of notes payable	0us-gaap_NotesPayableCurrent	3,894us-gaap_NotesPayableCurrent
Total current liabilities	5,359us-gaap_LiabilitiesCurrent	8,971us-gaap_LiabilitiesCurrent
Notes payable	0us-gaap_LongTermNotesPayable	973us-gaap_LongTermNotesPayable
Deferred tax liability - intangible assets	5,190	5,581
Deferred income taxes	985	995
TOTAL LIABILITIES	11,534us-gaap_Liabilities	16,520us-gaap_Liabilities
Stockholders' equity:
Preferred stock - $.01 par value; authorized - 5,000 shares; no shares issued or outstanding
Common stock - $.01 par value; authorized - 50,000 shares; issued - March 31, 2015, 3,753 shares and December 31, 2014, 3,748 shares	38us-gaap_CommonStockValue	37us-gaap_CommonStockValue
Accumulated other comprehensive income (loss)	(5,771)	(3,234)
Additional paid-in capital	3,001	2,890
Retained earnings	66,573	64,863
Total stockholders' equity	63,841us-gaap_StockholdersEquity	64,556us-gaap_StockholdersEquity
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$ 75,375	$ 81,076

Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 19

-Subparagraph a

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19(a))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682